Aladdin Healthcare Technologies SE

  • WKN: A12ULL
  • ISIN: DE000A12ULL2
  • Land: Deutschland

Nachricht vom 04.02.2020 | 11:59

Aladdin Healthcare Technologies SE: Announces we have achieved a top five position in Kaggle's Global Data Science Bowl 2019


DGAP-Media / 04.02.2020 / 11:59





Aladdin Healthcare Technologies SE: Announces we have achieved a top five position in Kaggle's Global Data Science Bowl 2019

(BERLIN, Germany and LONDON, England) 04 February 2020 Aladdin Healthcare Technologies SE ("Aladdin"), is proud to announce that two of its senior engineers, who are Kaggle Grand Masters, placed 5th out of 3,497 teams in the prestigious Global Data Science Bowl competition. Again, one of Aladdin's AI solutions has proven to be at a world class level. A standard that should set Aladdin on the path to innovation in global healthcare.

Aladdin's A.I team has achieved a large number of A.I competition 1st prize awards, including the first prize of 2018 ACM KDD CUP, DCIC 2019. And a large number of publications, including MICCAI, Nature Machine Intelligence, IEEE, Bioinformatics etc.

What is Data Science Bowl (DSB)?

DSB is the world's largest data science competition focused on social good. Each year, this competition gives Kagglers a chance to use their passion to change the world. Over the last four years, more than 50,000+ Kagglers have submitted over 114,000+ submissions, to improve everything from lung cancer and heart disease detection to ocean health. DataScienceBowl.com

Reference: https://www.kaggle.com/c/data-science-bowl-2019/leaderboard


Wade Menpes-Smith (Chairman)


About Aladdin Healthcare Technologies SE

Website Link: www.aladdinid.com
WKN: A12ULL
ISIN: DE000A12ULL2
TICKER SYMBOL: NMI

Aladdin Healthcare Technologies SE (and its wholly owned subsidiary Aladdin Healthcare Technologies Ltd.) is a leading developer of AI healthcare diagnostics and drug discovery applications that can accelerate both early stage disease diagnosis and the end-to-end drug discovery process. Aladdin targets aged related disease including a significant focus on Alzheimer's disease. Aladdin accomplishes this by collaborating with numerous partners within the global healthcare ecosystem to confidentially and securely gather targeted data including, genome, tabular, MRI, PET, cognition and other lifestyle data. These datasets are then analysed by our award-winning AI team and used to develop proprietary AI tools that can assist healthcare professionals to more accurately and efficiently diagnose aged related diseases. This new diagnostic process will save significant time and costs for healthcare professionals. Additionally, our AI drug discovery platform will be used to by pharmaceutical Companies to speed up drug development, clinical trials and predict outcomes more accurately.
 


End of Media Release


Issuer: Aladdin Healthcare Technologies SE
Key word(s): Health

04.02.2020 Dissemination of a Press Release, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

Northern Data AG: „Massiver Anstieg der Nachfrage durch Corona“

Die Frankfurter Northern Data AG (ISIN: DE000A0SMU87) hat sich innerhalb kürzester Zeit eine führende Position als Anbieter von Lösungen im High Performance Computing (HPC) erarbeitet. „Wir sprechen bereits heute von einem Markt im mittleren zweistelligen Milliardenbereich mit enormem Wachstum. Der gesamte Bereich explodiert nachfragemäßig vor unseren Augen“, erläutert CEO Aroosh Thillainathan im Financial.de-Interview. Pro Gigawatt peilt er einen Umsatz zwischen 400 und 500 Mio. Euro pro Jahr an, bei einer Bruttogewinnmarge von 40 bis 50 Prozent.

GBC-Fokusbox

MBH Corporation. Hohes Kurspotenzial

Die MBH Corporation plc hat in den vergangenen Berichtsperioden eine sehr hohe M&A-Aktivität aufgezeigt. Unter Anwendung der so genannten Agglomeration Methodology hat die Beteiligungsgesellschaft branchenübergreifend seit 2018 11 Beteiligungen erworben. Bei einem Pro-Forma-Umsatz der Beteiligungsgesellschaften von über 120 Mio. GBP und einem Pro-Forma-EBITDA in Höhe von über 11 Mio. GBP weist die MBH derzeit eine Marktkapitalisierung von umgerechnet gerade einmal 19,8 Mio. GBP auf. Ausgehend vom aktuellen Aktienkurs liegt zu unserem Kursziel in Höhe von 1,95 € ein hohes Kurspotenzial vor

News im Fokus

SAP SE: SAP veröffentlicht vorläufige Ergebnisse für das erste Quartal und aktualisiert Ausblick für 2020

08. April 2020, 23:39

Aktueller Webcast

SeaChange Corporation

Fourth Quarter Fiscal Year 2020 Results

06. April 2020

Aktuelle Research-Studie

Francotyp-Postalia Holding AG

Original-Research: Francotyp-Postalia Holding AG (von GSC Research GmbH): Kaufen

09. April 2020